Belite Bio BLTE
NASDAQ BLTE
$155.94 -0.58 (-0.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Belite Bio (BLTE) Change in Accrued Expenses (2024 - 2025)

Updated

Belite Bio (BLTE) reported Change in Accured Expenses of $1.84 million for Q4 2025, down 36.7% from $2.91 million a year earlier.

Analysis

Belite Bio (BLTE) Change in Accrued Expenses (2024 - 2025) Analysis & Trends

For FY2025, Belite Bio posted Change in Accured Expenses of $3.85 million, up 56.2% from FY2024.

  • Change in Accured Expenses has increased for three consecutive years.
  • By year, Change in Accured Expenses came in at $2.46 million in FY2024 (+73.3%), $1.42 million in FY2023 (+281.0%), $373,000 in FY2022 (-41.0%) and $632,000 in FY2021.
  • The Q4 2025 figure ranks as the lowest quarterly Change in Accured Expenses since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Belite Bio 6.16 Bn 6.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.84 Mn
Dec 31, 2024 2.91 Mn
API Access

Belite Bio Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BLTE&period=max&api_key=YOUR_API_KEY